Learning Objectives Communicate risk factors associated with not - - PDF document

learning objectives
SMART_READER_LITE
LIVE PREVIEW

Learning Objectives Communicate risk factors associated with not - - PDF document

Managing Sleep Health in Primary Care Managing Sleep Health in Primary Care Paul P. Doghramji, MD, FAAFP Family Practice Physician Collegeville Family Practice & Pottstown Medical Specialists, Inc. Medical Director of Health Services,


slide-1
SLIDE 1

Managing Sleep Health in Primary Care 1

Managing Sleep Health in Primary Care

Paul P. Doghramji, MD, FAAFP Family Practice Physician Collegeville Family Practice & Pottstown Medical Specialists, Inc. Medical Director of Health Services, Ursinus College – Collegeville, PA Attending Family Practice Physician, Pottstown Memorial Medical Center – Pottstown, PA

Learning Objectives

▪ Communicate risk factors associated with not getting enough sleep ▪ Explain the sleep/wake cycle and circadian rhythms ▪ Identify common sleep disorders in primary care ▪ Use appropriate diagnostic tools to assess patients’ sleep health

slide-2
SLIDE 2

Managing Sleep Health in Primary Care 2

Agenda

▪ What is sleep? ▪ Sleep stages ▪ Sleep physiology ▪ Dreaming ▪ Sleepiness ▪ Sleep disorders ▪ Insomnia and comorbidities

Sleep Perspectives

▪ Behavioral ▪ Reversible ▪ Perceptual disengagement from, and unresponsiveness to, the environment ▪ Neurophysiological ▪ Two distinct states: REM sleep and NREM ▪ Actively produced, not a result of passive inactivity ▪ Highly regulated by homeostatic and circadian processes ▪ Produces changes in the entire organism, not just the CNS ▪ Teleological ▪ Necessary for survival; deprivation leads to functional impairments and eventual death ▪ Important for clearance of neurotoxic waste products (e.g., beta amyloid) that accumulate in the brain during wakefulness

NREM = non-rapid eye movement Carskadon MA, Dement WC (2005), Normal human sleep: an overview. In: Principles and Practice of Sleep Medicine, 4th ed., Kryger MH et al., eds. Philadelphia: Elsevier/Saunders, pp13-23. Science vol 342, 18 Oct 2013.

slide-3
SLIDE 3

Managing Sleep Health in Primary Care 3

What does sleep do? The 4R’s of Sleep:

▪ Rest ▪ Restore ▪ Repair ▪ Rejuvenate

3 PROPER-ties of Sleep

▪ Proper duration ▪ Proper timing ▪ Proper quality ▪ Improper duration and/or timing and/or quality can lead to insufficient rest/restore/rejuvenate/repair -> poor health and decreased longevity

slide-4
SLIDE 4

Managing Sleep Health in Primary Care 4

Why is sleep important?

▪ Cognition and performance ▪ Mood regulation ▪ Mental health ▪ Physical health ▪ Safety

slide-5
SLIDE 5

Managing Sleep Health in Primary Care 5

Sleep Stages

SLEEP  REST

Two States of Sleep

Rapid eye movement (REM) sleep ▪ When dreaming occurs ▪ “Active brain in a paralyzed body”

Hours 1 N 1 & REM N 2 N3 2 3 4 5 6 7 8

Non-REM sleep ▪ 3 stages ▪ Based primarily on EEG

Typical Sleep Architectural Pattern of a Young Human Adult

Adapted from Hauri P. The Sleep Disorders. Kalamazoo, Mich: Upjohn;1982:8.

Stage I & REM sleep (red) are graphed on the same level because their EEG patterns are very similar

slide-6
SLIDE 6

Managing Sleep Health in Primary Care 6

Sleep Architecture

▪ Sleep is entered through stage N1 ▪ Orderly progression from stage N1 to N3 and, typically within 90 minutes of sleep onset, to the 1st REM period ▪ 90-minute cycle of REM-NREM repeats throughout sleep ▪ As the night progresses ▪ REM periods increase in duration and density of eye movements ▪ N3 sleep becomes less prominent in the 2nd half of the night

Sleep Stage Characteristics

NREM REM

Heart rate Steady Variable Blood pressure Steady Labile Respirations Regular Irregular Skeletal muscle tone Normal Decreased Thermoregulation Waking modes Decreased Penile tumescence Infrequent Frequent Mental activity Limited Dreaming Brain O2 consumption Decreased Waking level

Lee-Chiong T, ed. Sleep: A Comprehensive Handbook. Hoboken, NJ: Wiley & Sons; 2006.

slide-7
SLIDE 7

Managing Sleep Health in Primary Care 7

Sleep Across the Life Span

100 200 300 400 500 600 700 Total Sleep Time (min) Age (years) Total Time in Bed Awake in Bed NREM N 1 REM NREM N 2 NREM N 3 10 20 30 40 50 60 70 80 5

Adapted from Williams RL, et al. Electroencephalography of Human Sleep: Clinical Applications. New York, NY: John Wiley & Sons; 1974.

slide-8
SLIDE 8

Managing Sleep Health in Primary Care 8

Sleep Physiology

Brainstem Mechanisms Underlying Sleep and Arousal

slide-9
SLIDE 9

Managing Sleep Health in Primary Care 9

Orexin = Hypocretin

▪ Hypothalamic peptides (OX1 and OX2) ▪ Localized in the dorsolateral hypothalamus ▪ Wide projections throughout brain and spinal column ▪ Peptide neurotransmitters involved in ▪ Arousal ▪ Locomotion ▪ Metabolism (energy and appetite control) ▪ Increase blood pressure & heart rate

Peyron et al. J Neurosci. 1998;18:9996. Moore et al. Arch Ital Biol. 2001;139:195. Silber & Rye. Neurology. 2001;56:1616.

Flip Flop Switch Model of Arousal and Sleep

Awake Sleep

Modified from Saper CB, et al. Nature. 2005;437(7063):1257-1263.

slide-10
SLIDE 10

Managing Sleep Health in Primary Care 10

Dreaming

When do we dream?

▪ Dreaming occurs in all stages of sleep ▪ 80% of persons who are awakened during REM sleep and sleep onset (N1 & N2) ▪ 40% of persons who are awakened from a deep sleep

slide-11
SLIDE 11

Managing Sleep Health in Primary Care 11

Foulkes D. Dreaming: a cognitive-psychological analysis. Hillsdale, N.J.: Erlbaum, 1985.

N1 & N2 N3 REM Simpler, shorter and have fewer associations than REM sleep dreams More diffuse (e.g., about a color or an emotion) Tend to be bizarre and detailed, with storyline plot associations Highest recall during sleep stages with EEG patterns most like those in the waking state D R E A M S

REM and Non-REM Dreams Frightening Dreams

TYPE OF DREAM INCIDENCE SYMPTOMS SLEEP STAGE ASSOCIATED FACTORS Frequent nightmares in children 20% to 30%, declines with age Frightening, detailed plots Difficult return to sleep REM sleep, usually late in sleep (4 - 6 a.m.) Usually no pathology Frequent nightmares in adults 5% to 8% Increased awakenings Daytime memory impairment and anxiety REM sleep “Thin-boundary” / creative personality May have associated psychopathology PTSD 8% - 68% of veterans >25% of trauma victims Stereotypic dreams of the trauma Intense rage, fear, grief REM sleep and sleep

  • nset

Significant trauma Daytime hyper- arousability & anxiety REM sleep behavior disorder Most common in late middle age and in men Acting out of dreams Nocturnal injuries REM sleep  REM EMG tone Degenerative neurologic illness in 50% Night terrors 1% to 4% of children Declines with age Rare in adults Blood-curdling screams Autonomic discharge Limited recall Deep sleep, early (1- 3 a.m.) Stages 3 & 4 arousals on PSG No pathology in children Psychiatric & neurologic disorders in adults

PAGEL JF, Nightmares and Disorders of Dreaming. Am Fam Physician. 2000 Apr 1;61(7):2037-2042.

REM = rapid eye movement; EMG = electromyography

slide-12
SLIDE 12

Managing Sleep Health in Primary Care 12

Sleepiness

Sleepiness: How do patients describe it?

▪ “I’m tired all the time” ▪ “I have no energy” ▪ “I feel fatigued” ▪ “I feel depressed” ▪ “I don’t feel rested” ▪ “I don’t sleep well”

The International Classification of Sleep Disorders: Diagnostic and Coding Manual. 2nd ed. Westchester, IL: American Academy of Sleep Medicine; 2005. Chervin RD. Chest 2000;118:372-379. Shen J, et al. Sleep Med Rev 2006;10:63-76.

slide-13
SLIDE 13

Managing Sleep Health in Primary Care 13

Patients Also Mean Other Things “TIRED”

Sleepiness Fatigue Lack of motivation

Tendency to fall asleep or inability to stay awake Sensation of weariness, tiredness, exhaustion, loss of energy; the desire to rest “I don’t feel like doing anything…” Improved by sleep Improved by rest, exertion makes it worse

Sleepiness in America

37% 16% 0% 10% 20% 30% 40% At least a few days per month At least a few days per week

% of US Adults Reporting that They Are So Sleepy it Interferes with Their Daily Activities

National Sleep Foundation. “Sleep in America” Poll. March 2002.

slide-14
SLIDE 14

Managing Sleep Health in Primary Care 14

Assessment Options: Sleep Parameters

▪ Subjective: based on self-report

▪ Epworth ▪ Insomnia Severity Scale ▪ Diaries ▪ Often do not reflect objective sleep measures

▪ Objective: Sleep lab or home sleep monitor ▪ Wearable technology (eg, Fitbit) increasingly capable of more

  • bjective sleep assessment: eg, total sleep time, slow wave sleep,

REM sleep

▪ Not reimbursable, not validated in clinical practice

Epworth Sleepiness Scale

Johns MW. Sleep. 1991;14:540-545.

Rate the chances of dozing in sedentary situations

Never Slight Moderate High Sitting and reading 1 2 3 Watching television 1 2 3 Sitting, inactive in a public place (eg, a movie theater or a meeting) 1 2 3 As a passenger in a car for an hour without a break 1 2 3 Lying down to rest in the afternoon when circumstances permit 1 2 3 Sitting and talking to someone 1 2 3 Sitting quietly after lunch without alcohol 1 2 3 In a car, while stopped for a few minutes in the traffic 1 2 3

Score >=10 Prompts Further Evaluation

slide-15
SLIDE 15

Managing Sleep Health in Primary Care 15

US women 20.8%, US men 29.7%2

South Africa1 24.5% Japan1 12.4% China1 6.2% Austria1 17.5% Belgium1 17.5% Brazil1 14.3% Germany1 7.2% Portugal1 18.3% Slovakia1 13.7% Spain1 12.7% Norway3 17.7%

N=35,327 survey respondents aged 39 ± 15.3 years.1 ESS, Epworth Sleepiness Scale

  • 1. Soldatos CR, et al. Sleep Med. 2005;6:5-13; 2. Baldwin CM, et al. Sleep. 2004;27:305-311; 3. Pallesen S, et al. Sleep. 2007;30:619-624.

Worldwide Prevalence of ESS Scores >10

Categories of Sleepiness

▪ Insufficient sleep ▪ Factitious ▪ Insomnia ▪ Poor quality sleep ▪ Obstructive sleep apnea ▪ Restless Legs Syndrome ▪ Disturbed timing of sleep ▪ Circadian rhythm disorders ▪ Medications and substances ▪ Rx, OTC, herbals ▪ Illicit drugs, alcohol ▪ Brain “damage” ▪ MS, Parkinson’s, TBI, stroke, Alzheimer's ▪ Narcolepsy

slide-16
SLIDE 16

Managing Sleep Health in Primary Care 16

Sleep Disorders

Restless Legs Syndrome6

10%-15%

Comorbid Insomnias4

6%

Narcolepsy5

0.06%†

Obstructive Sleep Apnea1

3%-28%

Sleep-Wake Disorders: Prevalence in Adults

*Among night and rotating shift workers; †Prevalence of hypersomnias such as narcolepsy without cataplexy may be higher.

  • 1. Young T, et al. Am J Respir Crit Care Med. 2002;165:1217-1239.
  • 4. Ohayon MM. Sleep Med Rev. 2002;6:97-111.
  • 2. Drake CL, et al. Sleep. 2004;27:1453-1462.
  • 5. Silber MH, et al. Sleep. 2002;25:197-202.
  • 3. Strine DP, et al. Sleep Med. 2005;6:23-27.
  • 6. Merlino G et al. Neurol Sci. 2007;28:S37-S46.

†Mignot E, et al. Brain. 2006;129:1609-1623. †Singh M, et al. Sleep. 2006;29:890-895.

Shift Work Disorder2

8%-32%*

Insufficient Sleep Syndrome3

26%

slide-17
SLIDE 17

Managing Sleep Health in Primary Care 17

How to Diagnose the Cause of Sleepiness

▪ Get detailed sleep/wake history

▪ Determine whether sleepy, fatigue, or depression

▪ Quantify degree of sleepiness: ESS ▪ Start probing for the causes, looking for clues

▪ Insufficient Sleep Syndrome: doesn’t get enough sleep ▪ OSA: loud snoring, waking up choking, witnesses apneas, waking with sore throat, headache, enuresis, nocturia ▪ RLS: uncomfortable feelings in legs prevent sleep, need to move them to relieve symptoms ▪ PLMD: no clues except excessive sleepiness ▪ Narcolepsy: hypnogogic/hypnopompic hallucinations, sleep paralysis, cataplexy

Obstructive Sleep Apnea

Symptoms

▪ Loud Snoring ▪ Gasping, choking ▪ Witnessed apneas ▪ Morning headaches, sore throat ▪ Enuresis/nocturia

Physical Findings

▪ Large neck ▪ Crowded pharynx ▪ Obesity ▪ Micrognathia, short chin

Treatment

▪ CPAP/BiPAP/Auto-AP ▪ Oral appliance ▪ Surgery ▪ Weight loss ▪ Positioning ▪ “Provent” ▪ “Inspire”

slide-18
SLIDE 18

Managing Sleep Health in Primary Care 18

Screening for OSA: STOP-BANG Method

STOP Questionnaire* ▪ Snoring ▪ Tiredness (daytime) ▪ Observed you stop breathing during sleep ▪ High blood Pressure BANG† ▪ BMI > 35 ▪ Age > 50 years ▪ Neck circumference > 40 cm (~ 16 in) ▪ Gender: Male * High risk = Yes to > 2 of 4 STOP items † High risk = Yes to > 3 of 8 STOP-BANG items

Chung F, et al. Anesthesiology 2008;108:812-821.

Airway Assessment: OSA Mallampati Scale

Nuckton TJ, et al. Sleep. 2006;29:903-908.

Odds of OSA increase >2-fold for every 1-point increase

Class I Class II Class III Class IV

slide-19
SLIDE 19

Managing Sleep Health in Primary Care 19

Restless Leg Syndrome (RLS)

Symptoms

▪ Irresistible urge to move legs usually with unpleasant sensations ▪ Relief with movement ▪ Worse at night ▪ Worse with rest

Etiology

▪ Dopaminergic dysfunction ▪ Iron deficiency ▪ Renal insufficiencies ▪ Peripheral neuropathies ▪ 25% secondary

Treatment

▪ Dopaminergic agents ▪ Iron if deficient ▪ Sedative hypnotics ▪ Anticonvulsants ▪ Opiates ▪ Sleep hygiene

Allen RP, Sleep Med, 2003.

Periodic Limb Movement Disorder (PLMD)

  • vs. RLS

▪ Substantial overlap ▪ Up to 85% of RLS patients have PLMD ▪ 30% of PLMD patients have RLS ▪ RLS diagnosis is made clinically ▪ PLMD diagnosis is made via PSG ▪ No other daytime clues, just sleepiness ▪ Treatments are the same

slide-20
SLIDE 20

Managing Sleep Health in Primary Care 20

Insomnia and Comorbidities

Insomnia

As a disorder:

▪ Trouble getting to sleep and/or ▪ Trouble staying asleep and/or ▪ Waking up too early and/or ▪ Occurring more days of the week than not ▪ Ongoing for over 3 months

slide-21
SLIDE 21

Managing Sleep Health in Primary Care 21

Why Should PCP’s be Proactive about Insomnia?

▪ Very prevalent in primary care ▪ But patients don’t tell you ▪ Serious consequences ▪ Day to day life ▪ Poor outcome on mental and physical health ▪ Insomnia is a clue ▪ Most insomnia is co-morbid ▪ Easy to identify Treatment ▪ Relieves an upsetting symptom ▪ Improves next day consequences ▪ Improves outcome of co-morbidity ▪ Psychiatric ▪ Medical ▪ Majority is done by PCP

Insomnia Risk Factors

▪ Age (older) ▪ Sex (especially post-1 and perimenopausal2 females) ▪ Divorce / separation / widowhood ▪ Psychiatric illness (mood and anxiety disorders) ▪ Medical conditions ▪ Cigarette smoking ▪ Alcohol and coffee consumption ▪ Certain prescription drugs

  • 1. NIH Consens State Sci Statements. 2005;22:1-30.
  • 2. Young T, et al. Sleep. 2003;26:667-672.
slide-22
SLIDE 22

Managing Sleep Health in Primary Care 22

Insomnia Screening and Follow-up

▪ Sleep Schedule: Do you have trouble getting to sleep, staying asleep, or waking up too early? ▪ Daytime consequences: Do you feel like you have slept well throughout the day? ▪ Sleep timing: When do you go to bed? …Wake up? …Middle of the night awakening? …How long does it take you to fall back to sleep? ▪ Treatments: What remedies have you tried? Any previous Rx’s? ▪ Sleep hygiene/lifestyle issues: Alcohol? Smoking? Exercise? Medications that cause insomnia? ▪ Duration, frequency, prior: How long has this been going on?...How often?... Have you had it before?...

Sateia MJ, Doghramji K, Hauri PJ, Morin MM. Sleep. 2000;23:1-66. Erman MK. In: Sleep Disorders: Diagnosis and Treatment. Totowa, NY: Humana Press; 1998:21-51.

How Frequent are Comorbidities?

Terzano MG, et al. Sleep Med. 2004;5:67-75. Katz DA, McHorney CA. (1998). Clinical correlates of insomnia in patients with chronic illness. Arch Intern Med 158(10):1099-1107.

35 28 19 17 15 14 11

10 20 30 40 50

30 47 37 39 50 38 42

10 6 17 25 22 12 15

10 20 30 40 50

Insomnia Severe insomnia

Prevalence %

Medical Conditions in Primary Care Patients with Insomnia Insomnia with Medical Conditions

slide-23
SLIDE 23

Managing Sleep Health in Primary Care 23

How Does Inadequate Sleep Increase CVD?

▪ Total sleep time (TST) < 5 hours compared to TST > 5 hours ▪ Higher glucose & cortisol levels ▪ HPA-associated endocrine & metabolic imbalances ▪ Hypercholesterolemia even after controlling for other risk factors ▪ Night time BP: Nighttime SBP higher and day-to-night SBP dipping was lower (-8% vs -15%, P < 0.01) in insomniacs ▪ Atherosclerosis: Total sleep time (P = 0.005), and sleep quality (P = 0.05) contributed to increased carotid intima-media thickness ▪ Inflammation: Serum CRP levels higher and increased at a steeper rate

Lanfranchi, PA, et al. (2009). Nighttime blood pressure in normotensive subjects with chronic insomnia: implications for cardiovascular risk. Sleep 32(6): 760-766. Nakazaki, C, et al. (2012). Association of insomnia and short sleep duration with atherosclerosis risk in the elderly."Am J Hypertens 25(11): 1149-1155. Parthasarathy, S, et al. (2015). Persistent insomnia is associated with mortality risk. Am J Med 128(3): 268-275 e262. Lin, CL, et al. (2016). The relationship between insomnia with short sleep duration is associated with hypercholesterolemia: a cross-sectional study. J Adv Nurs 72(2): 339-347. Farina, B., et al. (2014). Heart rate and heart rate variability modification in chronic insomnia patients. Behav Sleep Med 12(4): 290-306. de Zambotti, M., et al. (2011). Sleep onset and cardiovascular activity in primary insomnia. J Sleep Res 20(2): 318-325.

Does insomnia contribute to development of hypertension?

Lewis, P. E., et al. (2014). Risk of type II diabetes and hypertension associated with chronic insomnia among active component, U.S. Armed Forces, 1998-2013. MSMR 21(10): 6-13.

Prospective Follow-up

▪ Active duty in US Military ▪ Excluded: Chronic insomnia prior to 1/1/1998 ▪ Without hypertension at baseline ▪ Chronic insomnia led to higher risk of hypertension (aHR 2.00)

Rate of Developing Hypertension

(per 10,000 person-years)

46.2 95.6 20 40 60 80 100

Controls Insomnia

slide-24
SLIDE 24

Managing Sleep Health in Primary Care 24

Does Insomnia Increase Risk of CVDs?

1.68 1.85 1.4 1.3

0.5 1 1.5 2

aOR of CV Event

0.96 1.35 4.53 1 2 3 4 5

1 2 3

aOR for CHF

1st CV Event

# Insomnia Symptoms

Hsu, CY , et al. (2015). The Association Between Insomnia and Increased Future Cardiovascular Events: A Nationwide Population-Based Study. Psychosom Med 77(7): 743-751. Laugsand, LE, et al. (2014). Insomnia and the risk of incident heart failure: a population study. Eur Heart J 35(21): 1382-1393. Canivet, C, et al. (2014). Insomnia increases risk for cardiovascular events in women and in men with low SES: a longitudinal, register- based study. J Psychosom Res 76(4): 292-299.

How Much Does Insomnia Contribute to CV Mortality?

Health Professionals Follow-Up Study ▪ US men free of cancer ▪ Insomnia symptoms in 2004, followed through 2010 ▪ Adjusted for age, lifestyle factors, and common chronic conditions Metaanalysis of 13 Prospective Studies ▪ 122,501 subjects followed for 3-20 yrs ▪ Insomnia increased risk by 45% of developing or dying from CVD

▪ (RR 1.45, 1.29-1.62; p < 0.00001)

Li, Y , et al. (2014). "Association between insomnia symptoms and mortality: a prospective study of U.S. men." Circulation 129(7): 737-746. Sofi, F, et al. (2014). Insomnia and risk of cardiovascular disease: a meta-analysis. Eur J Prev Cardiol 21(1): 57-64.

1.25 1.09 1.04 1 1.25 1.5

Total Mortality CVD Mortality

Difficulty Initiating & Nonrestorative

Difficulty initiating Difficulty maintaining Early-morning awakenings

1.55 (1.19-2.04) 1.32 (1.02-1.72) Health Professionals Follow-Up Study

Adjusted Hazards Ratio

slide-25
SLIDE 25

Managing Sleep Health in Primary Care 25

How Does Insomnia Contribute to Diabetes Risk?

Insulin Resistance Associated with Subjective Sleep Complaints In Those without Diabetes

ORs Adjusted for Insomnia Daytime Sleepiness Sex and age 1.68 (1.09–2.58) 1.80 (1.22–2.66) Fully* 1.24 (0.74–2.09) 1.75 (1.10–2.77) *Adjusting for sex, age, alcohol consumption, smoking, exercise, occupational status, BMI, and family history of diabetes

Pykkönen A-J, et al. (2012) Subjective Sleep Complaints Are Associated With Insulin Resistance in Individuals Without Diabetes. Diabetes Care 35:2271–8.

aORs for HbA1c >= 6.0%

6.79 3.96 2.33 2 4 6 8

Kachi, Y ., et al. (2011). Association between insomnia symptoms and hemoglobin A1c level in Japanese men. PLoS One 6(7): e21420.

Males 22-69 years old with no hx of diabetes Difficulty maintaining sleep

Lasting 2+wks

Early AM awakening

Some- times Some- times

Japanese company annual health check-up

Does Treating Insomnia Lower Blood Pressure?

Standard BP treatment + estazolam vs. Standard BP treatment + placebo ▪ Insomnia treatment efficacy

▪ Estazolam: 67.3% (P < 0.001) ▪ Placebo: 14.0%

▪ Goal BP(< 140/90 mmHg)

▪ Estazolam: 74.8% (P < 0.001) ▪ Placebo: 50.5%

Li, Y , et al. (2017). "The impact of the improvement of insomnia on blood pressure in hypertensive patients." J Sleep Res 26(1): 105-114.

Blood Pressure Reduction from Baseline

  • 2.6
  • 2.8
  • 2.5
  • 3.4
  • 2.3
  • 2
  • 2.5
  • 2.7
  • 0.7
  • 2.8
  • 5
  • 7.1
  • 2.5
  • 3.7
  • 5.4
  • 8
  • 6
  • 4
  • 2

7 14 21 28 7 14 21 28

Placebo Estazolam

Systolic Diastolic

N = 202 N = 200

Days of Treatment

slide-26
SLIDE 26

Managing Sleep Health in Primary Care 26

Does Insomnia Increase Risk of Psychiatric Disorders?

31.1 35.9 30 14.4 5 21 18 10 5 10 15 20 25 30 35 40

Patients (%)

Incidence (%) over 3.5 years

Insomnia (n=240) No Insomnia (n=739) Breslau N, Roth T, Rosenthal L, Andreski P. Sleep disturbance and psychiatric disorders: a longitudinal epidemiological study of young adults. Biol Psychiatry. 1996;39:411-418.

Does Treating Insomnia Improve Comorbidities?

20 40 60 80 100 4 Months 16 Months Poor Good 20 40 60 80 100 4 Months 16 Months Control Tai Chi

By Sleep Quality

% 4 months CBT .21 (.03-1.47)

p<.10

TCC NS 16 months CBT .06 (.005-.669)

p<.01

TCC .10 (.008-1.29)

p<.05 ORs of Remaining at High Risk 2-hour group sessions weekly for 4 mo with a 16-mo evaluation

Risk score based on 8 biomarkers: HDL, LDL, triglycerides, C-reactive protein, fibrinogen, HA1c, glucose, insulin

  • High risk = 4 or more abnormal

By Intervention

% Remaining at High Risk

Carroll, JE, et al. (2015). Improved sleep quality in older adults with insomnia reduces biomarkers of disease risk: pilot results from a randomized controlled comparative efficacy trial. Psychoneuroendocrinology 55: 184-192.

slide-27
SLIDE 27

Managing Sleep Health in Primary Care 27

How is Insomnia Best Conceptualized to Guide Treatment?

▪ Genetic: heritability 42% - 57% in chronic insomnia ▪ Final common pathway: Autonomic and CNS hyperarousal

▪ Greater whole-brain metabolism during both sleep and wake periods ▪ Increased secretion of corticotropin and cortisol throughout sleep-wake cycle

▪ Sleep-wake regulation imbalance

▪ Overactivity of arousal systems ▪ Hypoactivity of sleep-inducing systems ▪ Both

▪ Failure of wake-promoting structures to deactivate during the transition from waking to sleep states

Riemann D., et al. (2015). The neurobiology, investigation, and treatment of chronic insomnia. Lancet Neurol 14(5): 547-558. Vgontzas, AN, et al. (2013). Insomnia with objective short sleep duration: the most biologically severe phenotype of the disorder. Sleep Med Rev 17(4): 241-254. Vgontzas et al. Nofzinger et al. Am J of Psychiatry. 2004;161:2126-2128.

  • 1. Kupfer DJ, Reynolds CF III. N Engl J Med. 1997;336:341-346.
  • 2. Consensus Conference. JAMA. 1984;251:2410-2414.

Stepwise Approach for Managing Insomnia

Discuss With Patient How They Sleep

Diagnosis1, 2 Education, Including Good Sleep Practices1, 2 Nonpharma- cologic and/or Pharma- cologic Therapy1, 2 Referral to Sleep Specialist (In Cases of Treatment Failure)1

slide-28
SLIDE 28

Managing Sleep Health in Primary Care 28

Patient Education: Most Powerful Tool

▪ Inform WHY management is so important

▪ Consequences

▪ Emphasize keeping regimented sleep schedule

▪ Wake up same time every day ▪ Naps usually not a good idea

▪ Emphasize sleeping long enough

▪ Can’t catch up on weekends

▪ Emphasize lifestyle measures

▪ Alcohol, exercise, smoking, caffeine, diet (no large meals)

Treatments: CBT and/or Medications?

▪ Address the co-morbid condition as well as the insomnia ▪ Discuss with patient pros and cons of meds and CBT ▪ Medications: ▪ Which are best applicable? ▪ Habit forming? ▪ How long to use? ▪ Side effects? ▪ CBT: at your discretion—ability, time, interest ▪ Allow patient to voice his/her concerns, fears, and needs

slide-29
SLIDE 29

Managing Sleep Health in Primary Care 29

How Does Cognitive Behavioral Therapy Compare To Pharmacotherapy?

Adapted from: Jacobs GD, et al. Arch Intern Med. 2004;164:1888-1896. Schutte-Rodin S et al. J Clin Sleep Med. 2008;4(5):487-504. Morin CM, et al. Sleep 1999;22:1134-56.

CBT-I Components ▪ Sleep hygiene education ▪ Cognitive therapy ▪ Sleep restriction therapy ▪ Stimulus control therapy ▪ Relaxation training Sleep Hygiene ▪ Regular wake time ▪ Limit time awake and in bed ▪ Limit napping during the day ▪ Avoid clock watching if awake ▪ Avoid caffeine (after 2 PM), alcohol after dinner, or eating dinner just before bedtime ▪ Avoid stressful activities in the evening

Treating Insomnia: Choosing the Right Pharmacotherapy

▪ Trouble with sleep initiation only: rapid and short acting

▪ Ramelteon, triazolam, zaleplon, zolpidem

▪ Trouble staying asleep with sleep initiation problems: rapid and long acting

▪ Eszopiclone, temazepam, zolpidem ER, zolpidem (if awakes early in evening), suvorexant

▪ Trouble staying asleep withOUT sleep initiation problems

▪ Doxepin (taken at sleep onset), sublingual zolpidem (taken if one awakens)

▪ Issues with controlled substances: both of these unscheduled

▪ Ramelteon, doxepin

▪ Generic medications

▪ Temazepam, triazolam, zaleplon, zolpidem, eszopiclone

slide-30
SLIDE 30

Managing Sleep Health in Primary Care 30

When to Consider Referral to a Sleep Expert

▪ Suspected obstructive sleep apnea or narcolepsy1-3 ▪ Violent behaviors or unusual parasomnias1-3 ▪ Daytime tiredness (sleepiness) that you can’t figure out1 ▪ Insomnia fails to respond to behavioral and/or pharmacologic therapy after an appropriate interval1,3 ▪ You don’t feel comfortable treating the condition

  • 1. Doghramji P. J Clin Psychiatry. 2001;62(suppl 10):18-26.
  • 2. Sateia MJ, Owens J, Dube C, Goldberg R. Sleep. 2000;23:243-308.
  • 3. Kushida CA, Littner MR, Morgenthaler T, et al. Sleep. 2005;28:499-521.

Additional Resources

▪ For additional resources, visit: ▪ Sleepfoundation.org ▪ Sleep.org ▪ Sleephealthjournal.org